Processa’s Bigora shifts to part-time role in retirement transition

• Processa Pharmaceuticals set a transition for Chief Development and Regulatory Officer Sian Bigora as part of her planned move toward retirement.
• Bigora will shift to a part-time employee role effective May 1, 2026.
• She will keep her Chief Development and Regulatory Officer title while providing services in a reduced capacity.
• Her existing employment agreement will end, to be replaced by a new part-time employment arrangement effective May 1, 2026.
• Previously granted equity awards will remain in place under their existing terms.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Processa Pharmaceuticals Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-26-020728), on April 30, 2026, and is solely responsible for the information contained therein.